ArticleHealth science reports2025
Youth Should Be Part of African Pharma Industry-A Perspective.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Africa imports over 70% of its medicines and 90% of its vaccines. This situation makes the citizens vulnerable to medicine shortages and increased risk of substandard and counterfeit drugs. This article provides insights into the significance of African youth in tackling key challenges affecting local pharma industry. Methods: A literature review was conducted throughout September 2024 by retrieving articles from Google Scholar. Articles relevant to the aim of the study were snowballed, reviewed, analyzed, and considered during the preparation of this article. Results: African youth possess fresh energy, minds, and innovative skills, which are indispensable for the development of local pharmaceutical sector. They are capable of utilizing artificial intelligence, which can advance critical processes in the African pharma industry including research and development (R&D) as well as quality assurance. Nevertheless, inadequate access to education, training, and mentorship opportunities hinder their involvement. Conclusion: Established partnerships among local and international pharma industries, African universities, and other relevant stakeholders are essential to meaningful involvement of youth in the local pharma sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.